RGC – Regencell Bioscience Holdings Ltd

RGC — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

1.07

Margin Of Safety %

Put/Call OI Ratio

1.51

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

26.33

Target Price

Analyst Recom

Performance Q

4.35

Upside

-100.5%

Beta

2.26

Ticker: RGC

14 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	RGC	25.44	2.34	0.66	5013
2026-03-10	RGC	24.65	2.22	0.50	4956
2026-03-11	RGC	23.7	2.03	0.04	5270
2026-03-12	RGC	23.9	1.93	1.58	5357
2026-03-13	RGC	24	1.93	1.60	5357
2026-03-17	RGC	22.88	1.81	0.82	5457
2026-03-18	RGC	26.47	1.81	0.42	5434
2026-03-19	RGC	26.97	1.74	0.09	5759
2026-03-20	RGC	27.2	1.71	0.60	5804
2026-03-23	RGC	25.02	1.41	1.87	2655
2026-03-24	RGC	24.3	1.52	1.88	2790
2026-03-25	RGC	24.3041	1.53	0.36	2867
2026-03-26	RGC	25.27	1.52	1.50	2872
2026-03-27	RGC	25.68	1.51	1.18	2880
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

14 items 1 of 1

14 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	RGC	25.71	-	-	-
2026-03-10	RGC	24.66	-	-	-
2026-03-11	RGC	23.80	-	-	-
2026-03-12	RGC	24.12	-	-	-
2026-03-13	RGC	23.15	-	-	-
2026-03-17	RGC	22.98	-	-	-
2026-03-18	RGC	26.39	-	-	-
2026-03-19	RGC	26.96	-	-	-
2026-03-20	RGC	27.20	-	-	-
2026-03-23	RGC	25.16	-	-	-
2026-03-24	RGC	24.30	-	-	-
2026-03-25	RGC	24.38	-	-	-
2026-03-26	RGC	25.32	-	-	-
2026-03-27	RGC	26.33	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

14 items 1 of 1

14 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	RGC	0.00	-8.67	1.19
2026-03-10	RGC	0.00	-8.67	1.19
2026-03-11	RGC	0.00	-8.67	1.12
2026-03-12	RGC	0.00	-8.67	1.12
2026-03-13	RGC	0.00	-8.67	1.12
2026-03-17	RGC	0.00	-8.44	1.12
2026-03-18	RGC	0.00	-8.44	1.12
2026-03-19	RGC	0.00	-8.44	1.12
2026-03-20	RGC	0.00	-8.44	1.12
2026-03-23	RGC	0.00	-7.57	1.12
2026-03-24	RGC	0.00	-7.57	1.12
2026-03-25	RGC	0.00	-7.57	1.07
2026-03-26	RGC	0.00	-7.57	1.07
2026-03-27	RGC	0.00	-7.57	1.07
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

14 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-7.57

Beta

2.26

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.2

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

2611.39

P/Free Cash Flow

EPS

-0.01

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.46

Return on Equity vs Sector %

-101.1

Return on Equity vs Industry %

-80.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ RGC Healthcare

$25.67

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

15/25

Volume

11/15

Valuation

6/20

TP/AR

2/10

Options

3/10

RSI

50.1

Range 1M

40.7%

Sup Dist

5.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

11/30

Estimates

0/20

Inst/Vol

2/15

Options

1/10

EPS Yr

EPS NY

52W%

28.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

Quality

2/30

Valuation

2/30

Growth

6/25

Stability

6/10

LT Trend

1/5

Quality

Regencell Bioscience Holdings L

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 10

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

RGC

Latest News

—

Caricamento notizie per RGC…

stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today

news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance

stock history RGC – Regencell Bioscience Holdings Ltd invest stock market

stock prices RGC premarket after hours

ticker RGC fair value insiders trading

SIMO – Silicon Motion Technology Corporation

SIMO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

1.33

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

1.24

Price

109.97

Target Price

158.56

Analyst Recom

Performance Q

23.55

Upside

15.4%

Beta

1.08

Ticker: SIMO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	SIMO	129.17	0.48	0.04	11823
2026-03-02	SIMO	129.17	0.43	0.05	12893
2026-03-03	SIMO	119.12	0.43	26.62	12905
2026-03-04	SIMO	122.31	0.65	0.07	14938
2026-03-05	SIMO	122.76	0.75	0.03	14034
2026-03-06	SIMO	118.69	0.66	0.40	15205
2026-03-09	SIMO	121.64	0.66	1.55	15235
2026-03-10	SIMO	122.94	0.66	0.26	15286
2026-03-11	SIMO	123.62	0.66	1.10	15411
2026-03-12	SIMO	120.19	0.66	0.45	15544
2026-03-13	SIMO	120.11	0.66	0.44	15544
2026-03-17	SIMO	126.16	0.65	0.36	15822
2026-03-18	SIMO	125.27	0.65	2.01	15874
2026-03-19	SIMO	127.5	0.66	0.76	15980
2026-03-20	SIMO	123.86	0.66	0.40	15996
2026-03-23	SIMO	123.61	0.16	0.08	8006
2026-03-24	SIMO	118.48	0.15	0.62	8907
2026-03-25	SIMO	111	0.16	0.06	9344
2026-03-26	SIMO	111.26	0.14	0.50	11012
2026-03-27	SIMO	109.93	0.14	0.48	11021
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	SIMO	129.20	119.2	-	5.76
2026-03-02	SIMO	129.15	119.2	-	5.76
2026-03-03	SIMO	119.16	119.2	-	5.76
2026-03-04	SIMO	122.42	119.2	-	5.76
2026-03-05	SIMO	123.60	117.2	-	5.66
2026-03-06	SIMO	118.53	117.2	-	5.66
2026-03-09	SIMO	121.63	117.2	-	5.66
2026-03-10	SIMO	122.91	117.2	-	5.66
2026-03-11	SIMO	123.42	117.2	-	5.66
2026-03-12	SIMO	120.31	117.2	-	5.66
2026-03-13	SIMO	123.46	117.2	-	5.66
2026-03-17	SIMO	126.35	117.2	-	5.66
2026-03-18	SIMO	125.20	117.2	-	5.66
2026-03-19	SIMO	127.46	117.2	-	5.66
2026-03-20	SIMO	123.76	117.2	-	5.66
2026-03-23	SIMO	123.54	117.2	-	5.66
2026-03-24	SIMO	118.47	117.2	-	5.66
2026-03-25	SIMO	110.81	117.2	-	5.66
2026-03-26	SIMO	111.36	117.2	-	5.66
2026-03-27	SIMO	109.97	117.2	-	5.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	SIMO	0.00	-2.84	1.97
2026-03-02	SIMO	0.00	-0.61	1.97
2026-03-03	SIMO	0.00	-0.61	1.97
2026-03-04	SIMO	0.00	-0.61	1.97
2026-03-05	SIMO	0.00	-0.61	1.97
2026-03-06	SIMO	0.00	-0.61	1.97
2026-03-09	SIMO	0.00	-0.58	1.97
2026-03-10	SIMO	0.00	-0.58	1.97
2026-03-11	SIMO	0.00	-0.58	1.59
2026-03-12	SIMO	0.00	-0.58	1.59
2026-03-13	SIMO	0.00	-0.58	1.59
2026-03-17	SIMO	0.00	-0.58	1.59
2026-03-18	SIMO	0.00	-0.58	1.59
2026-03-19	SIMO	0.00	-0.58	1.59
2026-03-20	SIMO	0.00	-0.58	1.59
2026-03-23	SIMO	0.00	-0.57	1.59
2026-03-24	SIMO	0.00	-0.57	1.59
2026-03-25	SIMO	0.00	-0.57	1.33
2026-03-26	SIMO	0.00	-0.57	1.33
2026-03-27	SIMO	0.00	-0.57	1.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

1.3

Avg. EPS Est. Next Quarter

1.21

Insider Transactions

Institutional Transactions

-0.57

Beta

1.08

Average Sales Estimate Current Quarter

299

Average Sales Estimate Next Quarter

307

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.1

Max Drawdown 5-Year %

-56.5

Target Price

158.56

P/E

30.34

Forward P/E

14.72

PEG

0.31

P/S

4.23

P/B

4.49

P/Free Cash Flow

595.52

EPS

3.63

Average EPS Est. Cur. Y

5.66

EPS Next Y. (Est.)

6.89

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.81

Relative Volume

0.43

Return on Equity vs Sector %

-42.1

Return on Equity vs Industry %

-44.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.79

EBIT Estimation

◆ SIMO Technology

$110.06

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

25/25

Volume

11/15

Valuation

13/20

TP/AR

4/10

Options

5/10

RSI

34.4

Range 1M

7.6%

Sup Dist

2.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

13/25

Growth

26/30

Estimates

6/20

Inst/Vol

4/15

Options

7/10

EPS Yr

62.7%

EPS NY

29.5%

52W%

65.8%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +97.7% upside

Quality

12/30

Valuation

19/30

Growth

20/25

Stability

8/10

LT Trend

0/5

Upside

+97.7%

Quality

Silicon Motion Technology Corpo

Sector: Technology

Industry: Semiconductors

Employees:

Silicon Motion Technology Corporation, together with its subsidiaries, designs, develops, and markets NAND flash controllers for solid-state storage devices and related devices in Taiwan, the United States, Korea, China, Malaysia, Singapore, and internationally. The company offers controllers for computing-grade solid state drives (SSDs), which are used in PCs and other client devices; enterprise-grade SSDs used in enterprise and hyperscale data centers; eMMC and UFS mobile embedded storage for use in smartphones and IoT devices; flash memory cards and flash drives for use in expandable storage; and specialized SSDs that are used in industrial, commercial, and automotive applications. It markets its controllers under the SMI brand; and single-chip SSDs under the FerriSSD, Ferri-eMMC, and Ferri-UFS brands. The company markets and sells its products through direct sales personnel and independent electronics distributors to NAND flash makers, module makers, hyperscalers, and OEMs. Silicon Motion Technology Corporation was founded in 1995 and is based in Hong Kong, Hong Kong.

SIMO

Latest News

—

Caricamento notizie per SIMO…

stock quote shares SIMO – Silicon Motion Technology Corporation Stock Price stock today

news today SIMO – Silicon Motion Technology Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch SIMO – Silicon Motion Technology Corporation yahoo finance google finance

stock history SIMO – Silicon Motion Technology Corporation invest stock market

stock prices SIMO premarket after hours

ticker SIMO fair value insiders trading

NHTC – Natural Health Trends Corp.

NHTC — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.62

Margin Of Safety %

Put/Call OI Ratio

0.93

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.77

Target Price

Analyst Recom

Performance Q

-9.74

Upside

-137.4%

Beta

0.85

Ticker: NHTC

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	NHTC	3.13	1.07	0.00	455
2026-03-03	NHTC	3.1	1.07	999.99	455
2026-03-04	NHTC	3.19	1.09	0.00	459
2026-03-06	NHTC	3.19	1.05	999.99	466
2026-03-09	NHTC	3.09	1.05	999.99	466
2026-03-10	NHTC	3.23	1.04	0.00	463
2026-03-11	NHTC	3.04	1.04	0.00	463
2026-03-12	NHTC	3.08	1.07	0.00	456
2026-03-13	NHTC	3.12	1.07	0.00	456
2026-03-17	NHTC	2.83	1.07	0.00	457
2026-03-18	NHTC	2.78	1.02	999.99	467
2026-03-20	NHTC	2.8	1.02	999.99	467
2026-03-25	NHTC	2.82	0.93	0.00	446
2026-03-26	NHTC	2.86	0.93	0.00	446
2026-03-27	NHTC	2.77	0.93	0.00	446
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	NHTC	3.18	-	-	-
2026-03-02	NHTC	3.12	-	-	-
2026-03-03	NHTC	3.13	-	-	-
2026-03-04	NHTC	3.20	-	-	-
2026-03-05	NHTC	3.10	-	-	-
2026-03-06	NHTC	3.15	-	-	-
2026-03-09	NHTC	3.10	-	-	-
2026-03-10	NHTC	3.17	-	-	-
2026-03-11	NHTC	3.09	-	-	-
2026-03-12	NHTC	3.08	-	-	-
2026-03-13	NHTC	3.07	-	-	-
2026-03-17	NHTC	2.85	-	-	-
2026-03-18	NHTC	2.79	-	-	-
2026-03-19	NHTC	2.90	-	-	-
2026-03-20	NHTC	2.80	-	-	-
2026-03-23	NHTC	2.82	-	-	-
2026-03-24	NHTC	2.72	-	-	-
2026-03-25	NHTC	2.82	-	-	-
2026-03-26	NHTC	2.84	-	-	-
2026-03-27	NHTC	2.77	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	NHTC	0.00	-19.79	0.63
2026-03-02	NHTC	0.00	-19.79	0.63
2026-03-03	NHTC	0.00	-19.79	0.85
2026-03-04	NHTC	0.00	-19.79	0.85
2026-03-05	NHTC	0.00	-19.79	0.85
2026-03-06	NHTC	0.00	-19.79	0.85
2026-03-09	NHTC	0.00	-19.79	0.85
2026-03-10	NHTC	0.00	-19.79	0.85
2026-03-11	NHTC	0.00	-19.79	0.70
2026-03-12	NHTC	0.00	-19.79	0.70
2026-03-13	NHTC	0.00	-19.79	0.70
2026-03-18	NHTC	0.00	-19.79	0.70
2026-03-19	NHTC	0.00	-19.79	0.70
2026-03-20	NHTC	0.00	-19.79	0.70
2026-03-23	NHTC	0.00	-19.79	0.70
2026-03-24	NHTC	0.00	-19.79	0.70
2026-03-25	NHTC	0.00	-19.79	0.62
2026-03-26	NHTC	0.00	-19.79	0.62
2026-03-27	NHTC	0.00	-19.79	0.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-19.79

Beta

0.85

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

66.4

Max Drawdown 5-Year %

-67

Target Price

P/E

Forward P/E

PEG

P/S

0.6

P/B

1.37

P/Free Cash Flow

EPS

-0.08

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2.22

Relative Volume

0.45

Return on Equity vs Sector %

-20.6

Return on Equity vs Industry %

-22.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ NHTC Consumer Cyclical

$2.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

20/25

Volume

11/15

Valuation

6/20

TP/AR

2/10

Options

2/10

RSI

38.2

Range 1M

20.5%

Sup Dist

0.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

4/30

Estimates

1/20

Inst/Vol

0/15

Options

2/10

EPS Yr

EPS NY

52W%

11.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

Quality

6/30

Valuation

2/30

Growth

0/25

Stability

6/10

LT Trend

1/5

Quality

Natural Health Trends Corp. - C

Sector: Consumer Cyclical

Industry: Internet Retail

Employees: 118

Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, such as liquid, encapsulated, tableted and powder dietary and nutritional supplements, vitamins, and minerals; and herbal products, including herbal supplements. It also provides beauty products comprising facial skin care, hand and body care, age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products consisting of weight management and energy enhancing supplements, as well as topical gels. In addition, the company offers at-home testing kits for measuring critical biomarkers of well-being, including cardiovascular, hormonal, inflammatory, metabolic, and nutritional health. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, the Cayman Islands, Mexico, Peru, and Colombia; Hong Kong, Taiwan, and China; Malaysia and Singapore; South Korea; Russia and Kazakhstan; Japan; India; and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Rolling Hills Estates, California.

NHTC

Latest News

—

Caricamento notizie per NHTC…

stock quote shares NHTC – Natural Health Trends Corp. Stock Price stock today

news today NHTC – Natural Health Trends Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch NHTC – Natural Health Trends Corp. yahoo finance google finance

stock history NHTC – Natural Health Trends Corp. invest stock market

stock prices NHTC premarket after hours

ticker NHTC fair value insiders trading

MSC – Studio City International Holdings Ltd ADR

MSC — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

3.29

Target Price

Analyst Recom

Performance Q

17.01

Upside

-219.6%

Beta

0.03

Ticker: MSC

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	MSC	2.92	N/A	N/A	0
2026-03-03	MSC	2.95	N/A	N/A	0
2026-03-04	MSC	2.8	N/A	N/A	0
2026-03-06	MSC	2.85	N/A	N/A	0
2026-03-09	MSC	2.85	N/A	N/A	0
2026-03-10	MSC	3.07	N/A	N/A	0
2026-03-11	MSC	3.03	N/A	N/A	0
2026-03-12	MSC	2.92	N/A	N/A	0
2026-03-13	MSC	3	N/A	N/A	0
2026-03-17	MSC	3.03	N/A	N/A	0
2026-03-18	MSC	2.78	N/A	N/A	0
2026-03-20	MSC	2.3	N/A	N/A	0
2026-03-25	MSC	2.21	N/A	N/A	0
2026-03-26	MSC	2.83	N/A	N/A	0
2026-03-27	MSC	3.23	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	MSC	3.02	-	-	-
2026-03-02	MSC	2.92	-	-	-
2026-03-03	MSC	3.24	-	-	-
2026-03-04	MSC	2.89	-	-	-
2026-03-05	MSC	2.89	-	-	-
2026-03-06	MSC	2.85	-	-	-
2026-03-09	MSC	2.80	-	-	-
2026-03-10	MSC	3.00	-	-	-
2026-03-11	MSC	2.92	-	-	-
2026-03-12	MSC	3.04	-	-	-
2026-03-13	MSC	2.82	-	-	-
2026-03-17	MSC	3.01	-	-	-
2026-03-18	MSC	3.02	-	-	-
2026-03-19	MSC	2.50	-	-	-
2026-03-20	MSC	2.31	-	-	-
2026-03-23	MSC	2.40	-	-	-
2026-03-24	MSC	2.30	-	-	-
2026-03-25	MSC	2.70	-	-	-
2026-03-26	MSC	2.84	-	-	-
2026-03-27	MSC	3.29	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	MSC	0	22.22	0.01
2026-03-02	MSC	0	22.22	0.01
2026-03-03	MSC	0	22.22	0.01
2026-03-04	MSC	0	22.22	0.01
2026-03-05	MSC	0	22.22	0.01
2026-03-06	MSC	0	22.22	0.01
2026-03-09	MSC	0	21.84	0.01
2026-03-10	MSC	0	21.84	0.01
2026-03-11	MSC	0	21.84	0.01
2026-03-12	MSC	0	21.84	0.01
2026-03-13	MSC	0	21.84	0.01
2026-03-18	MSC	0	22.22	0.01
2026-03-19	MSC	0	22.22	0.01
2026-03-20	MSC	0	22.22	0.01
2026-03-23	MSC	0	22.22	0.01
2026-03-24	MSC	0	22.22	0.01
2026-03-25	MSC	0	22.22	0.00
2026-03-26	MSC	0	22.22	0.00
2026-03-27	MSC	0	22.22	0.00
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

22.22

Beta

0.03

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

3.97

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

79.2

Max Drawdown 5-Year %

-89

Target Price

P/E

Forward P/E

PEG

P/S

0.93

P/B

1.36

P/Free Cash Flow

EPS

-0.31

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.46

Relative Volume

41.72

Return on Equity vs Sector %

-27.1

Return on Equity vs Industry %

-37.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ MSC Consumer Cyclical

$3.37

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

2/25

Volume

3/15

Valuation

15/20

TP/AR

2/10

Options

0/10

RSI

61.7

Range 1M

55.8%

Sup Dist

34.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

10/30

Estimates

2/20

Inst/Vol

10/15

Options

0/10

EPS Yr

EPS NY

52W%

13%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +101.2% upside

Quality

5/30

Valuation

21/30

Growth

4/25

Stability

2/10

LT Trend

1/5

Upside

+101.2%

Quality

MoS

21%

Studio City International Holdi

Sector: Consumer Cyclical

Industry: Resorts & Casinos

Employees: 5879

Studio City International Holdings Limited provides provision of services pursuant to a casino contract and the hospitality business in Macau. It operates gaming services, a casino contract for the operation of studio city casino, focusing on mass market and premium mass market table games and gaming machines, including baccarat, three-card baccarat, blackjack, craps, caribbean stud poker, roulette, sic bo, fortune 3 card poker, and other games; hospitality services; dining services; event and convention services; other services; leasing services; and resort, which offers various non-gaming attractions, including figure-8 ferris wheel, nightclub and karaoke venue, live performance arena, and an outdoor and indoor water park, as well as live performance arena and various food and beverage establishments, and retail space. The company was formerly known as Cyber One Agents Limited and changed its name to Studio City International Holdings Limited in January 2012. The company was founded in 2000 and is based in Central, Hong Kong. Studio City International Holdings Limited is a subsidiary of MCO Cotai Investments Limited.

MSC

Latest News

—

Caricamento notizie per MSC…

stock quote shares MSC – Studio City International Holdings Ltd ADR Stock Price stock today

news today MSC – Studio City International Holdings Ltd ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch MSC – Studio City International Holdings Ltd ADR yahoo finance google finance

stock history MSC – Studio City International Holdings Ltd ADR invest stock market

stock prices MSC premarket after hours

ticker MSC fair value insiders trading

FUTU – Futu Holdings Limited

FUTU — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

3.56

Margin Of Safety %

Put/Call OI Ratio

1.24

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

9.41

Price

133.96

Target Price

228.16

Analyst Recom

1.1

Performance Q

-18.66

Upside

168.9%

Beta

0.42

Ticker: FUTU

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	FUTU	148.39	1.46	0.59	67634
2026-03-03	FUTU	144.7	1.48	2.65	64666
2026-03-04	FUTU	146.26	1.45	0.63	65003
2026-03-06	FUTU	143.54	1.39	0.70	66757
2026-03-09	FUTU	143.23	1.49	0.42	62618
2026-03-10	FUTU	153.68	1.42	0.31	64432
2026-03-11	FUTU	152.74	1.24	1.07	69386
2026-03-12	FUTU	143	1.25	0.78	74288
2026-03-13	FUTU	143.01	1.25	0.78	74288
2026-03-17	FUTU	147.22	1.25	1.22	70895
2026-03-18	FUTU	145.14	1.24	1.16	72191
2026-03-20	FUTU	134.85	1.17	1.12	72722
2026-03-25	FUTU	140.55	1.25	0.65	53094
2026-03-26	FUTU	136.43	1.24	0.92	53780
2026-03-27	FUTU	133.93	1.24	1.50	54336
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	FUTU	148.92	70.8	-	78.02
2026-03-02	FUTU	149.58	70.8	-	78.02
2026-03-03	FUTU	144.69	70.8	-	78.02
2026-03-04	FUTU	146.29	70.8	-	78.02
2026-03-05	FUTU	144.49	70.8	-	78.02
2026-03-06	FUTU	143.51	70.8	-	78.02
2026-03-09	FUTU	143.19	70.8	-	78.02
2026-03-10	FUTU	153.56	70.8	-	78.02
2026-03-11	FUTU	152.66	70.8	-	78.02
2026-03-12	FUTU	143.01	70.8	-	78.02
2026-03-13	FUTU	141.15	70.8	-	78.02
2026-03-17	FUTU	147.27	33.9	-	96.23
2026-03-18	FUTU	144.68	33.9	-	96.23
2026-03-19	FUTU	139.47	33.9	-	96.23
2026-03-20	FUTU	134.99	33.9	-	96.23
2026-03-23	FUTU	140.12	33.9	-	96.23
2026-03-24	FUTU	140.21	33.9	-	96.29
2026-03-25	FUTU	140.55	33.9	-	96.29
2026-03-26	FUTU	136.37	33.9	-	96.29
2026-03-27	FUTU	133.96	33.9	-	96.29
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	FUTU	0.00	-5.74	4.02
2026-03-02	FUTU	0.00	-5.56	4.02
2026-03-03	FUTU	0.00	-5.56	4.02
2026-03-04	FUTU	0.00	-5.56	4.02
2026-03-05	FUTU	0.00	-5.56	4.02
2026-03-06	FUTU	0.00	-5.56	4.02
2026-03-09	FUTU	0.00	-5.56	4.02
2026-03-10	FUTU	0.00	-5.56	4.02
2026-03-11	FUTU	0.00	-5.56	3.40
2026-03-12	FUTU	0.00	-5.56	3.40
2026-03-13	FUTU	0.00	-5.56	3.40
2026-03-17	FUTU	0.00	-5.97	3.40
2026-03-18	FUTU	0.00	-5.97	3.40
2026-03-19	FUTU	0.00	-5.97	3.40
2026-03-20	FUTU	0.00	-5.97	3.40
2026-03-23	FUTU	0.00	-6.14	3.40
2026-03-24	FUTU	0.00	-6.14	3.40
2026-03-25	FUTU	0.00	-6.14	3.56
2026-03-26	FUTU	0.00	-6.14	3.56
2026-03-27	FUTU	0.00	-6.14	3.56
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

26.35

Avg. EPS Est. Next Quarter

28.58

Insider Transactions

Institutional Transactions

-6.14

Beta

0.42

Average Sales Estimate Current Quarter

5789

Average Sales Estimate Next Quarter

5630

Fair Value

Quality Score

Growth Score

100

Sentiment Score

Actual DrawDown %

33.9

Max Drawdown 5-Year %

-86.4

Target Price

228.16

P/E

13.02

Forward P/E

9.55

PEG

0.59

P/S

4.33

P/B

3.98

P/Free Cash Flow

EPS

10.29

Average EPS Est. Cur. Y

96.29

EPS Next Y. (Est.)

105.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

49.62

Relative Volume

0.81

Return on Equity vs Sector %

15.4

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

6.71

EBIT Estimation

◆ FUTU Financial

$133.94

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

7/15

Valuation

15/20

TP/AR

2/10

Options

2/10

RSI

37.4

Range 1M

13.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

20/30

Estimates

6/20

Inst/Vol

1/15

Options

3/10

EPS Yr

18.1%

EPS NY

15.8%

52W%

48.4%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +1921.6% upside

Quality

23/30

Valuation

19/30

Growth

14/25

Stability

5/10

LT Trend

3/5

Upside

+1921.6%

Quality

Futu Holdings Limited

Sector: Financial Services

Industry: Capital Markets

Employees:

Futu Holdings Limited provides digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. The company offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. It also provides financial information and online community services; online wealth management services under the Money Plus brand name through its Futubull and moomoo platforms, which provides its client access to mutual funds, private funds, bonds, structured products, and other wealth management products; market data and information services; and NiuNiu Community, an open forum for users and clients to share insights, ask questions, and exchange ideas. Futu Holdings Limited was founded in 2007 and is headquartered in Admiralty, Hong Kong.

FUTU

Latest News

—

Caricamento notizie per FUTU…

stock quote shares FUTU – Futu Holdings Limited Stock Price stock today

news today FUTU – Futu Holdings Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch FUTU – Futu Holdings Limited yahoo finance google finance

stock history FUTU – Futu Holdings Limited invest stock market

stock prices FUTU premarket after hours

ticker FUTU fair value insiders trading

HCM – HUTCHMED (China) Limited

HCM — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.16

Margin Of Safety %

Put/Call OI Ratio

1.17

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.14

Price

13.77

Target Price

21.23

Analyst Recom

1.33

Performance Q

2.14

Upside

564.0%

Beta

0.44

Ticker: HCM

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	HCM	14.44	1.57	0.00	172
2026-03-02	HCM	13.82	1.57	0.00	172
2026-03-03	HCM	13.46	1.57	0.00	172
2026-03-04	HCM	13.61	1.57	0.00	172
2026-03-05	HCM	13.86	1.57	0.00	172
2026-03-06	HCM	13.73	N/A	N/A	0
2026-03-09	HCM	13.84	N/A	N/A	0
2026-03-10	HCM	13.8	1.57	999.99	172
2026-03-11	HCM	14.63	1.57	999.99	172
2026-03-12	HCM	14.09	1.57	999.99	172
2026-03-13	HCM	14.19	1.57	999.99	172
2026-03-17	HCM	14.28	1.57	0.00	172
2026-03-18	HCM	14.17	1.46	0.00	177
2026-03-19	HCM	13.96	1.36	999.99	182
2026-03-20	HCM	13.9	1.36	999.99	182
2026-03-23	HCM	14.03	1.38	999.99	183
2026-03-24	HCM	14.09	1.38	999.99	183
2026-03-25	HCM	14.19	1.16	999.99	166
2026-03-26	HCM	14.08	1.17	999.99	167
2026-03-27	HCM	13.87	1.17	999.99	167
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	HCM	14.32	-	80.9	1.45
2026-03-02	HCM	13.79	-	-63.6	1.45
2026-03-03	HCM	13.43	-	-65.5	1.45
2026-03-04	HCM	13.72	-	-68.3	1.45
2026-03-05	HCM	13.85	-	-68.2	1.45
2026-03-06	HCM	13.78	-	-65.9	1.45
2026-03-09	HCM	13.81	-	-66.3	0.37
2026-03-10	HCM	13.80	-	-545.7	0.34
2026-03-11	HCM	14.68	-	-550.1	0.51
2026-03-12	HCM	14.15	-	-545.1	0.51
2026-03-13	HCM	13.89	-	-547.5	0.40
2026-03-17	HCM	14.38	-	-491.2	0.40
2026-03-18	HCM	14.18	-	-492.0	0.40
2026-03-19	HCM	13.91	-	-492.6	0.40
2026-03-20	HCM	13.94	-	-491.3	0.40
2026-03-23	HCM	13.95	-	-491.8	0.40
2026-03-24	HCM	14.03	-	-491.9	0.40
2026-03-25	HCM	13.95	-	-491.9	0.40
2026-03-26	HCM	13.92	-	-492.2	0.40
2026-03-27	HCM	13.77	-	-492.1	0.38
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	HCM	0.00	-0.73	0.18
2026-03-02	HCM	0.00	-0.85	0.18
2026-03-03	HCM	0.00	-0.85	0.18
2026-03-04	HCM	0.00	-0.85	0.18
2026-03-05	HCM	0.00	-0.85	0.18
2026-03-06	HCM	0.00	-0.85	0.18
2026-03-09	HCM	0.00	-0.93	0.18
2026-03-10	HCM	0.00	-0.93	0.18
2026-03-11	HCM	0.00	-0.93	0.19
2026-03-12	HCM	0.00	-0.93	0.19
2026-03-13	HCM	0.00	-0.93	0.19
2026-03-17	HCM	0.00	-0.74	0.19
2026-03-18	HCM	0.00	-0.74	0.19
2026-03-19	HCM	0.00	-0.74	0.19
2026-03-20	HCM	0.00	-0.74	0.19
2026-03-23	HCM	0.00	-0.72	0.19
2026-03-24	HCM	0.00	-0.72	0.19
2026-03-25	HCM	0.00	-0.72	0.16
2026-03-26	HCM	0.00	-0.72	0.16
2026-03-27	HCM	0.00	-0.72	0.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.72

Beta

0.44

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.7

Max Drawdown 5-Year %

-82.2

Target Price

21.23

P/E

5.26

Forward P/E

30.04

PEG

P/S

4.38

P/B

1.95

P/Free Cash Flow

EPS

2.62

Average EPS Est. Cur. Y

0.38

EPS Next Y. (Est.)

0.52

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

83.28

Relative Volume

0.9

Return on Equity vs Sector %

9.6

Return on Equity vs Industry %

29.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-492.1

◆ HCM Healthcare

$13.81

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

7/15

Valuation

15/20

TP/AR

2/10

Options

0/10

RSI

Range 1M

39.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

13/30

Estimates

5/20

Inst/Vol

2/15

Options

0/10

EPS Yr

-87.8%

EPS NY

44.9%

52W%

29.2%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +38.1% upside

Quality

25/30

Valuation

10/30

Growth

8/25

Stability

6/10

LT Trend

4/5

Upside

+38.1%

Quality

HUTCHMED (China) Limited

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1796

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It provides Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to treat pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

HCM

Latest News

—

Caricamento notizie per HCM…

stock quote shares HCM – HUTCHMED (China) Limited Stock Price stock today

news today HCM – HUTCHMED (China) Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch HCM – HUTCHMED (China) Limited yahoo finance google finance

stock history HCM – HUTCHMED (China) Limited invest stock market

stock prices HCM premarket after hours

ticker HCM fair value insiders trading

No more stocks to show

RGC – Regencell Bioscience Holdings Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RGC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SIMO – Silicon Motion Technology Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SIMO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y